Photofrin as a radiosensitizer in an in vitro cell survival assay

Biochemical and Biophysical Research Communications

Volumn 311, Issue 1, 2003, Pages 98-103

  Kulka, Ulrike ^a   Schaffer, Moshe ^a   Siefert, Axel ^a   Schaffer, Pamela M ^a   Ölsner, Astrid ^a   Kasseb, Kawser ^b,c   Hofstetter, Alfons ^a   Dühmke, Eckhart ^a   Jori, Giulio ^b,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF PADOVA   (Italy)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Ionizing irradiation; Photofrin II; Radiation therapy; Radioresistant; Radiosensitizer

Indexed keywords

PHOTOFRIN II; RADIOSENSITIZING AGENT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTROCYTOMA CELL; BLADDER CANCER; CANCER CELL CULTURE; CELL DEATH; CELL SURVIVAL; COLON ADENOCARCINOMA; COLONY FORMATION; DRUG CYTOTOXICITY; DRUG EFFICACY; HUMAN; HUMAN CELL; HYPOXIC CELL; INCUBATION TIME; INTERMETHOD COMPARISON; IRRADIATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE;

EID: 0142027185     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.09.170     Document Type: Article

References (28)

1. Stewart F., Baas P., Star W. What does photodynamic therapy have to offer radiation oncologist (or their cancer patients)? Radiother. Oncol. 48:1988;233-248.
2. McDonald I.J., Dougherty T.J. Basic principles of photodynamic therapy. J. Porphyrins Phthalocyanines. 5:2001;105-129.
3. Jori G. Tumour photosensitizers: approaches to enhance the efficiency and selectivity of photodynamic therapy. J. Photochem. Photobiol. B. 36:1996;87-93.
4. Byrne C.J., Morshallsay L.V., Wand A.D. The chemical composition of Photofrin. J. Photochem. Photobiol. B. 61:1990;13-27.
5. Kavarnos G., Nath R., Bongiorni P. Visible light and X irradion of chinese hamster lung cells treated with hematoporphyrin derivative. Radiat. Res. 137:1994;196-201.
6. Wasserman T.H., Chapman J.D., Coleman C.N., Kligerman M.M. Chemicals as modifiers of radiation. Perez C.A., Brady L.W. Principles and Practice of Radiation Oncology. third ed. 1997;685-704 Lipincot Raven Publisher, Philadelphia.
7. Cohen L., Schwartz S. Modification of radiosensitivity by porphyrins II. Transplanted rhabdomyosarcoma in mice. Cancer Res. 26:1966;1769-1773.
8. Schaffer M., Schaffer P., Vogesser M., Ertl-Wagner B., Rauch J., Oberneder R., Jori G., Hofstetter A., Dühmke E. The application of Photofrin II as a specific radiosensitzing agent, in patients with bladder cancer, report of two cases. Photochem. Phobiol. Sci. 1:2002;686-689.
9. S. Schwartz, K. Absolon, H. Vermund, Some relationships of porphyrins, X-rays, and tumors, Medical Bulletin 27, University of Minesota, 1955, pp. 7-13.
10. Kostron H., Shwartz M., Miller D.C., Martuza R. The interaction of hematoporphyrin derivative, light and ionizing radiation in rat glioma model. Cancer. 57:1986;964-970.
11. O' Hara J., Douple E.B., Abrams M.J., Picker D.J., Giandomenico M., Vollano J. Potentiation of radiation induced cell kill by synthetic metalloporphyrins. Int. J. Radiat. Oncol. Biol. Phys. 16:1993;1049-1052.
12. Mehta M.P., Shapiro W.R., Glantz M.J., Patchell R.A., Weitzner M.A., Meyers C.A., Schultz C.J., Roa W.H., Leibenhaut M., Ford J., Curan W., Phan S., Miller R.A., Renschler M.F. Lead in phase to randomized trial of motexafin gadolinium and whole brain radiation for patients with brain metastases. Centralized assessment of magnetic resonance imaging, neurocognitive and neurologic end points. J. Clin. Oncol. 20:2002;3445-3453.
13. Viala J., Vanel D., Meingan P., Lartigau E., Carde P., Renschler M. Phases IB and II multidose trial of gadolinium texaphyrin, a radiation sensitizer detectable at MR imaging: preliminary results in brain metastases. Radiology. 212:1999;755-759.
14. Schaffer M., Schaffer P.M., Corti L., Gardiman M., Sotti G., Hofstetter A., Jori G., Dühmke E. Photofrin as a specific radiosensitising agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model. J. Photochem. Photobiol. B. 66:2002;157-164.
15. Schaffer M., Schaffer P.M., Corti L., Sotti G., Hofstetter A., Jori G., Dühmke E. Photofrin II as an efficient radiosensitising agent in an experimental tumour. Onkologie. 24:2001;482-485.
16. Schaffer M., Schaffer P.M., Jori G., Corti L., Sotti G., Hofstetter A., Dühmke E. Radiation therapy combined with Photofrin or 5-ALA-effect on Lewis Sarcoma Tumor lines implanted on mice - preliminary results. Tumori. 88:2002;408-411.
17. Acevedo-Duncan M., Pearlman J., Zachariah B. Sensitivity of human glioma U-373MG cells to radiation and the protein kinase C inhibitor, calphostin C. Cell Prolif. 34:2001;31-41.
18. Ahlering T.E., Dubeau L., Jones P.A. A new in vivo model to study invasion and metastasis of human bladder carcinoma. Cancer Res. 47:1997;6660-6665.
19. Budach W., Gioioso D., Taghian A., Stuschke M., Suit H.D. Repopulation capacity during fractionated irradiation of squamous cell carcinoma and glioblastomas in vitro. Int. J. Radiat. Oncol. Biol. Phys. 39:1997;743-750.
20. Fickweiler S., Steinbach P., Wörle K., Hofstädter F. The combined effects of high energy shock waves and ionising radiation on human bladder cancer cell line. Ultrasound Med. Biol. 22:1996;1097-1102.
21. Taghian A., DuBios W., Budach W. In vivo radiation sensitivity of glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;99-104.
22. Wouters B.G., Skarsgard L.D. Low-dose radiation sensitivity and induced radioresistance to cell killing in HT-29 cells is distinct from the adaptive response and cannot be explained by a subpopulation of sensitive cells. Radiat. Res. 148:1997;435-442.
23. Li X.T., Hellmann K. Antitumor effect of RA233 alone and combined with radiotherapy. Clin. Exp. Metastasis. 1:1983;181-190.
24. Schwartz S., Krepios N., Modelevsky J., Freyholz H., Waltens R., Larson L. Modification of radiosensitivity by porphyrins: studies of tumors and other systems. Moss M. Diagnosis and Therapy of Porphyrins and Lead Intoxication. 1978;227-235 Springer, Berlin.
25. Withers H.R., McBride W.H. Biologic basis of radiation therapy. Perez C.A., Brady L.W. Principles and Practice of Radiation Oncology. 1995;79-118 Lippincott-Raven Publisher, Philadelphia.
26. Rowinsky E.K. Novel radiation sensitizers targeting tissue hypoxia. Oncology. 13:1999;61-70.
27. Gupta A.K., McKenna W.G., Weber C.N., Feldman M.D., Goldsmith J.D., Mick R., Machtay M., Rosenthal D.I., Bakanauskas V.J., Cerniglia G.J., Bernhard E.J., Weber R.S., Muschel R.J. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin. Cancer Res. 8:2002;885-892.
28. Dougherty T.J., Cooper M.T., Mang T.S. Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Surg. Med. 10:1990;485-485.